Precursors of Cardiovascular Disease and Emerging Strategies With StatinsCMEDyslipidemia is only one signal of cardiovascular disease (CVD) risk. Inflammation is a frequent precursor of cardiac-related events. Drs. Willerson, Ballantyne, and Ridker critically examine the mechanisms of atherosclerosis, elevated C-reactive protein and other risk factors, and statin therapy to preemptively address or ameliorate CVD.
Stent Thrombosis: A Case-Based DiscussionCMEDr. Holmvang presents 2 cases of stent thrombosis to Dr. Kristensen outlining risk factors and potential strategies to prevent this catastrophic event.
The Genetics of Antiplatelet Responsiveness CMECarriers of certain CYP genetic variants have lower levels of clopidogrel's active metabolite and experience higher rates of MACE. What role should genotyping play in optimizing antiplatelet therapy? Dr. Simon discusses recent data on these topics with Dr. Mega.
MedscapeCME Ob/Gyn & Women's Health, November 2009
Lipid Insights from the AHA 2009CMEDr. Michael Davidson will lead a targeted discussion focusing on the interpretation and application of results presented at this year's AHA meeting. Joining him will be Dr. Christie Ballantyne, Dr. Vera Bittner and Dr. Roger Blumenthal.